The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer
Authors
Keywords
-
Journal
Journal of Ovarian Research
Volume 5, Issue 1, Pages 9
Publisher
Springer Nature
Online
2012-03-19
DOI
10.1186/1757-2215-5-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of dachshund 2 protein as a novel biomarker of poor prognosis in epithelial ovarian cancer
- (2012) Björn Nodin et al. Journal of Ovarian Research
- G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer
- (2011) Atanas Ignatov et al. BREAST CANCER RESEARCH AND TREATMENT
- GPR30 Activation Opposes Estrogen-Dependent Uterine Growth via Inhibition of Stromal ERK1/2 and Estrogen Receptor Alpha (ERα) Phosphorylation Signals
- (2011) Fei Gao et al. ENDOCRINOLOGY
- The GPER1 Agonist G-1 Attenuates Endothelial Cell Proliferation by Inhibiting DNA Synthesis and Accumulating Cells in the S and G2 Phases of the Cell Cycle
- (2011) Anders Holm et al. JOURNAL OF VASCULAR RESEARCH
- Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer
- (2010) Donal J Brennan et al. BMC CANCER
- Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21 and induction of G2 cell-cycle arrest
- (2010) Q K Y Chan et al. CELL DEATH AND DIFFERENTIATION
- Estradiol Attenuates EGF-Induced Rapid uPAR Mobilization and Cell Migration via the G-protein-Coupled Receptor 30 in Ovarian Cancer Cells
- (2010) Emir Henic et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer
- (2010) Åsa Ehlén et al. Journal of Translational Medicine
- G protein-coupled estrogen receptor 1 (GPER, GPR 30) in normal human endometrium and early pregnancy decidua
- (2010) Z. Kolkova et al. MOLECULAR HUMAN REPRODUCTION
- G Protein-Coupled Estrogen Receptor 1/G Protein-Coupled Receptor 30 Localizes in the Plasma Membrane and Traffics Intracellularly on Cytokeratin Intermediate Filaments
- (2010) C. Sanden et al. MOLECULAR PHARMACOLOGY
- Estrogen Receptor Subtypes in Ovarian Cancer
- (2010) Karen K. L. Chan et al. OBSTETRICS AND GYNECOLOGY
- Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival
- (2010) Björn Nodin et al. Journal of Ovarian Research
- Stimulating the GPR30 Estrogen Receptor with a Novel Tamoxifen Analogue Activates SF-1 and Promotes Endometrial Cell Proliferation
- (2009) Benjamin C. Lin et al. CANCER RESEARCH
- GPR30 predicts poor survival for ovarian cancer
- (2009) Harriet O. Smith et al. GYNECOLOGIC ONCOLOGY
- Ovarian cancer cells stimulate uPA gene expression in fibroblastic stromal cells via multiple paracrine and autocrine mechanisms
- (2009) Vera Noskova et al. GYNECOLOGIC ONCOLOGY
- Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer
- (2009) Annika Jögi et al. MODERN PATHOLOGY
- The G Protein-Coupled Receptor GPR30 Inhibits Human Urothelial Cell Proliferation
- (2008) Jian Teng et al. ENDOCRINOLOGY
- Estrogen Regulates Snail and Slug in the Down-Regulation of E-Cadherin and Induces Metastatic Potential of Ovarian Cancer Cells through Estrogen Receptor α
- (2008) Se-Hyung Park et al. MOLECULAR ENDOCRINOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started